Celebrex drug trial shows its risks
257790
Celebrex, a huge-selling painkiller sold by Pfizer, more than tripled the risk of heart attacks, strokes and death among those taking high doses in a national trial, the company said Friday.
31876
Studies questioning the safety of the drugs Celebrex and Aleve have created a quandary for patients: If every drug that relieves their pain has worrisome side effects, what do they do?
742151
The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.    One key researcher charged the U.S...
391974
Several pain medicines in the United States have been linked to an increase in heart attacks and strokes. Pfizer Drug Company says a new study shows that high levels of Celebrex increase the risk of heart attack.
762997
For the people who have followed closely the unfolding concerns about popular arthritis medicines, the news that Celebrex may also be linked to a higher risk of stroke and heart attack holds little surprise.
445497
Pfizer said that it would sponsor a major clinical trial of Celebrex, its prescription arthritis pain medication, to assess the cardiovascular benefits of the drug.
466531
New evidence shows all popular arthritis painkillers known as COX-2 inhibitors may put users at greater risk of heart attacks and strokes, the latest addition to the recent crop of safety concerns for the drugs.
3564
A day after troubling reports about the popular pain relief drug Celebrex, more questions are being asked about the approval process for such drugs.
377206
A study of the arthritis drug Celebrex casts doubt on the company's insistence that it had no hint of the drug's potential heart and stroke risks until recently.
408582
Pfizer Inc. said today that it had found an increased risk of heart troubles in some people taking higher dosages of Celebrex, its popular arthritis and pain relief drug.
127685
FRIDAY, Dec. 17 (HealthDayNews) -- The U.S. government announced Friday it has  halted the use of Celebrex in a cancer trial because of heart risks, and it is reviewing the safety of all its clinical trials using similar painkillers.
247867
Pfizer on Sunday reaffirmed its commitment to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis, despite a disclosure last week that the drug had increased the risk of heart attacks, strokes and death among some
288359
Pfizer Inc. on Friday said a government-sponsored cancer-prevention trial of its blockbuster arthritis drug Celebrex was halted after patients taking it had more than
301330
New prescriptions for Pfizer Inc.&#39;s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, according to Verispan, a market research company
98895
Drugmaker Pfizer announced Friday that its painkiller Celebrex puts patients at &quot;increased cardiovascular risk&quot; for heart problems, citing a long-term cancer study.
387871
Oct. 6, 2004 - Scientists in the United States and regulatory agencies in Europe on Wednesdsay questioned whether Celebrex and other pain relievers might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
535351
A new study finds that Celebrex, a painkiller from the family of cox-2-inhibitors, is safer than Vioxx, when it comes to the risk for heart attack.